MAMari Ala-Houhala

Mari Ala-Houhala

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mari Ala-Houhala has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Candidemia in adult patients with alcoholism: a retrospective cohort study in Finland from 2007 to 2016

    by Klaus Kessel, Erik Forsblom, Asko Järvinen, Mari Ala-Houhala

    Candidemia is a life-threatening, typically nosocomial infection, which often occurs with critical illness and immunosuppression. Alcoholism has not been associated with candidemia risk or outcomes. However, alcoholism is a common comorbidity in hospitalised patients, excess alcohol consumption has detrimental effects on the immune system, and alcoholism is associated with poor outcomes from bacteraemia, sepsis and bacterial pneumonia. We aimed to investigate the patient and disease characteristics, treatment, outcomes, and Candida species distribution in patients with alcoholism. We collected retrospective data on cases of candidemia in adults from Southern Finland between 2007 and 2016. Cases were stratified by alcoholism. We identified a total of 329 patients with candidemia, of which 69 (21%) had alcoholism. Patients with alcoholism were younger and had fewer serious or life-threatening comorbidities. Classical risk factors for candidemia were equally or less prevalent in patients with alcoholism than in those without, including malignancy (20% vs. 34%), central venous catheter (48% vs. 50%), and gastrointestinal surgery (20% vs. 24%). The majority of candidemia cases were nosocomial (92%) without significant differences between patient cohorts. Candidemia diagnosis in the ICU was more common in patients with alcoholism than in those without (19% vs. 10%). Central venous catheters were removed (61%) and antifungal therapy was initiated promptly in patients with alcoholism. The 30-day mortality of patients with and without alcoholism was equivalent (29% vs. 31%). A significant proportion of patients with candidemia had comorbid alcoholism. Patients with alcoholism did not have significantly different outcomes from patients without alcoholism.

  • Chronic Reactive Arthritis Following Bacillus Calmette-Guérin (BCG) Instillations: A Case Report and Review

    by Hermon Eyob Fesseha, Mohammadreza Shoghli, Laura Sundell, Mari Ala-Houhala, Alexandra Häme, Siyamak Jalal Hosseini, Yosan Eyob

    Background: Reactive arthritis (ReA) is an inflammatory joint condition that typically develops days to weeks after a gastrointestinal or genitourinary infection. While it is often associated with a classic triad of arthritis, urethritis, and conjunctivitis, many patients may not exhibit all three symptoms. Previously known as “Reiter syndrome,” named after Hans Reiter, ReA is thought to result from an abnormal autoimmune response to infections caused by pathogens such as Salmonella, Shigella, Campylobacter, or Chlamydia. Recognizing this connection is essential for effective diagnosis and treatment. Case Description: A 67-year-old male developed reactive arthritis (ReA) following intravesical Bacillus Calmette-Guérin (iBCG) therapy for non-muscle invasive bladder cancer. Elevated inflammatory markers and a negative HLA-B27 result were noted. The symptoms were attributed to iBCG-related ReA, leading to the discontinuation of iBCG treatment. Outcome: Initial treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids was ineffective, necessitating disease-modifying antirheumatic drugs (DMARDs) for sustained remission and symptom control. Although chronic arthritis requiring prolonged DMARD therapy is uncommon, the patient required over 1.5 years of DMARD treatment to manage symptoms effectively. Keywords: iBCG intravesical Bacillus Calmette-Guérin, DMARD disease-modifying antirheumatic drugs, NSAIDs nonsteroidal anti-inflammatory drugs

  • Characteristics of late recurrent candidemia in adult patients

    by Mari Ala‐Houhala, Veli‐Jukka Anttila

    Background and objectives: Candida species are one of the most common causes of health care‐associated bloodstream infections. However, recurrent candidemia is rare, and the characteristics of late recurrent (LR) candidemia are partly unclear. Our aim was to evaluate the characteristics of LR candidemia in adult patients.Patients and Methods: A retrospective cohort study was performed in the hospital district of Helsinki and Uusimaa in Finland (2007‐2016). All candidemia cases were searched in an electronic database during the study period. Patients with LR candidemia were compared with patients with a single candidemia episode to evaluate the characteristics of LR candidemia. LR candidemia was defined as having at least two episodes of candidemia more than 30 days apart.Results: We identified 24 episodes of LR candidemia in 20 patients. Patients with LR candidemia represented 6% of all patients with candidemia during the study period, and most of these cases were nosocomial. The median time between the first and the recurrent episode was 5.1 months. One‐year mortality in LR candidemia was 45%. Underlying gastrointestinal disease (OR 7.21, 95% CI 2.52‐20.61) and history of intra‐venous drug use (IVDU) (OR 3.62, 95% CI 1.03‐12.69) were independent risk factors for LR candidemia in the multivariable analysis.Conclusion: Our study indicates that the gastrointestinal tract may be a continuous source of infection in patients with chronic gastrointestinal diseases. Gastrointestinal diseases and IVDU should be regarded as risk factors for LR candidemia.


  • Open Access

    Persistent vs non‐persistent candidaemia in adult patients in 2007‐2016: A retrospective cohort study

    by Mari Ala‐Houhala, Veli‐Jukka Anttila

    Summary: Objectives: Persistent candidaemia (PC) is a recognised complication of candidaemia. Our objective was to evaluate risk factors and clinical significance of PC in adult patients.Methods: This is a retrospective, cohort study. We compared PC with non‐PC. All patients with blood cultures positive for Candida species were identified from a microbiological database in the hospital district of Helsinki and Uusimaa from 2007 to 2016. PC was defined as an isolation of the same Candida species from positive blood culture for ≥5 days.Results: PC criteria were fulfilled by 75/350 patients (21.4%). No significant difference emerged between persistent and non‐persistent cases caused by non‐albicans Candida species (37.3% vs 35.1%, P = .742). The length of hospital stay before onset of candidaemia was longer before PC (hospital stay > 7 days; 73.3% vs 59.6%, P = .043). No significant impact on 30‐day mortality was observed (20.0% vs 15.5%, P = .422). Using multivariable regression analysis, we found the presence of central venous catheter (CVC) (OR = 2.71, 95% CI 1.31‐5.59), metastatic infection foci (OR 3.60, 95% CI 1.66‐7.79) and ineffective empirical treatment (OR = 3.31, 95% CI 1.43‐7.65) to be independent risk factors for PC. In subgroup analysis, early source control was identified as a protective factor against PC (30.5% vs 57.7%, P = .002).Conclusion: The presence of CVC, metastatic infection foci and ineffective empirical treatment were independently associated with PC in adult patients. Active search for and treatment of metastatic infection foci and removal of CVC are key elements for preventing PC.


  • Clinical and microbiological factors associated with mortality in candidemia in adult patients 2007–2016

    by Mari Ala-Houhala, Miia Valkonen, Elina Kolho, Nathalie Friberg, Veli-Jukka Anttila

    Background: Candidemia is a life-threatening infection with high mortality. Our aim was to evaluate the Candida species distribution, antifungal susceptibilities and risk factors associated with 30-day mortality in candidemia in Southern Finland. Methods: We present a retrospective analysis of candidemia cases from the hospital district of Helsinki and Uusimaa during 2007–2016. Patients younger than 18 years old were excluded. A total of 386 candida isolates from 374 episodes of candidemia were identified in 350 adult patients. Results: Candida albicans was the leading cause of candidemia (60.4%), followed by C. glabrata (21.5%), C. parapsilosis (5.2%) and C. dubliniensis (5.2%). There was no statistically significant change in the distribution of C. albicans vs non-albicans species during the study period. Thirty-day overall mortality was 30.7%. When patients who received no antifungal treatment were excluded from the mortality analysis, 30-day mortality was 23.0%. Severity of underlying illnesses (OR 20.55, 95% CI 5.98–70.60), ICU stay at the onset of candidemia (OR 5.06, 95% CI 1.75–14.68) and age >65 years (OR 3.98, 95% CI 1.97–8.02) were independent risk factors of 30-day mortality in multivariable analysis. However, there was no statistically significant association between 30-day mortality and an early start of an effective antifungal. Conclusion: There was not a significant shift to non-albicans species as the cause of candidemia in Southern Finland during the 10-year study period. Furthermore, we did not find an association between 30-day mortality and the early start of an antifungal treatment. Comorbidity considerably increased the risk of fatal outcome.


    • 1 January 2013
      • Vol. 129  (5) , 528-35

    [Tuberculosis is transmitted in hospital and autopsy room--an epidemic in healthcare personnel].

    by Veli-Jukka Anttila, Leena Forss-Latvala, Eeva Ruotsalainen, Maria Laari, Pekka Saarelainen, Tuija Kerttula, Jussi Eskola

    We describe an epidemic of tuberculosis of occupational origin in five healthcare workers, which originated from a patient with tuberculous peritonitis. The source of the infection was not revealed until one year after the patient's death. Over 300 workers were exposed to tuberculosis. Up-to-date microbiological molecular technology was applied to the investigation of the infection among the exposed workers. This was the first time that an electronic reporting system for biological exposures was utilized for the investigation of an epidemic. Within this epidemic it is assumed that another five workers will develop a symptomatic tuberculosis infection during their lifetime.

  • Nosocomial candidaemia in a Finnish tertiary care centre during 1987–2004

    by Eira Poikonen, Outi Lyytikäinen, Veli-Jukka Anttila, Pentti Kuusela, Pirkko Koukila-Kähkölä, Jukka Ollgren, Petri Ruutu

    We studied the epidemiology of nosocomial candidaemia by assessing the incidence and outcome of illness and causative species in a large Finnish tertiary care centre during 1987-2004. A total of 364 episodes were observed; annual incidence varied between 0.26 per 10,000 patient-d in 2000 and 0.59 in 1989. The most common species were C. albicans (65%), C. parapsilosis (13%), and C. glabrata (9%). The proportion of C. albicans decreased from 71% during 1987-1992 to 58% during 1999-2004, and C. glabrata increased from 3% to 14%, respectively. The proportion of intensive care patients increased from 27% during 1987-1992 to 44% by 1999-2004, associated with neonates and surgical patients. The 1-month case fatality ranged from 30% to 33%. Nosocomial candidaemias did not increase, but the distribution of Candida spp. changed. Mortality remained high. The observed changes may reflect differences in prevention strategies that need to be explored for further improvements in prevention.